Description
A PDE9A inhibitor (IC50 = 22 nM); is selective for PDE9A over PDE1C (IC50 = >1,000 nM), as well as over a variety of other PDEs, inhibiting PDE2-8, -10, and -11 activity by less than 30% in a panel of enzymes, ion channels, and transporters at 1 µM but does inhibit the human dopamine transporter (DAT; Ki = 293 nM); increases cGMP CSF levels in rats; increases the rate of dendritic spine formation and elimination in mouse primary motor cortex pyramidal neurons in vivo at 10 mg/kg; increases the average running speed of mice in an accelerating rotarod task at 10 mg/kg
Formal name: 1,5-dihydro-6-[(1R)-1-(3-phenoxy-1-azetidinyl)ethyl]-1-(tetrahydro-2H-pyran-4-yl)-4H-pyrazolo[3,4-d]pyrimidin-4-one
Synonyms:
Molecular weight: 395.5
CAS: 1236858-52-8
Purity: ≥98%
Formulation: A solid